CN Patent

CN103073508B — 激酶抑制剂及治疗相关疾病的方法

Assigned to Beijing Reciprocapharmaceuticals Co ltd · Expires 2016-06-01 · 10y expired

What this patent protects

本说明激酶抑制剂及治疗相关疾病的方法描述的是(氨基苯基氨基)嘧啶基苯甲酰胺类化合物的分子结构，及其合成方法，以及使用该类化合物抑制激酶的方法和对B细胞有关的疾病的治疗。

USPTO Abstract

本说明激酶抑制剂及治疗相关疾病的方法描述的是(氨基苯基氨基)嘧啶基苯甲酰胺类化合物的分子结构，及其合成方法，以及使用该类化合物抑制激酶的方法和对B细胞有关的疾病的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN103073508B
Jurisdiction
CN
Classification
—
Expires
2016-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Reciprocapharmaceuticals Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.